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Metalloinsertors are substitutionally inert, octahedral transition metal complexes 
that bind to thermodynamically destabilized mismatched sites in duplex DNA with high 
affinity and selectivity. The complexes approach DNA from the minor groove, eject the 
mismatched bases into the major groove, and replace the displaced bases in the helical π-
stack with their own sterically expansive ligands. Herein, we describe a series of five 
investigations aimed at elucidating the generality of metalloinsertion at DNA defects. 
In an effort to develop a diagnostic for mismatched DNA, a bifunctional, 
mismatch-specific conjugate with rhodium metalloinsertor and fluorophore subunits has 
been constructed. A proof-of-concept conjugate was successfully produced that displays 
an almost fourfold fluorescence enhancement in the presence of mismatched versus 
matched DNA.  
To investigate the range of metal complexes capable of mismatch-specific 
metalloinsertion, a ruthenium bisdipyridyl complex bearing the heptacyclic eilatin ligand 
has been synthesized and characterized. Electrophoresis competition experiments 
illustrate that the complex does display mismatch-preferential, though not necessarily 
mismatch-selective, binding.  
To probe the generality of metalloinsertion at other common thermodynamically 
destabilized DNA defects, the binding of rhodium metalloinsertors at abasic sites and 
single base bulges has been studied. It was determined that metalloinsertors bind abasic 
sites with high affinity and specificity, without regard to the identity of the unpaired base 
and with little dependence on the sequence context of the defect. Single base bulge 
 vi 
recognition proved more elusive, with both the identity of the unpaired base and the 
sequence context influencing recognition.  
To determine the structural generality of metalloinsertion, single crystal X-ray 
diffraction was employed to determine the structure of Δ-Rh(bpy)2(chrysi)3+ bound to an 
oligonucleotide duplex containing two A•A mismatches. Two structures were obtained at 
< 2 Å resolution, and each provides an archetypical picture of metalloinsertion: the bulky 
rhodium complex inserts into the mismatched site from the minor groove, ejecting the 
mismatched bases and replacing the displaced base pair with its own sterically expansive 
ligand.  
Finally, two mismatch-specific conjugates have been designed for 
chemotherapeutic applications: a metalloinsertor-oxaliplatin conjugate for the selective 
delivery of platinum chemotherapeutics to mismatch repair deficient cells and a 
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